Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-049325

OPKO HEALTH, INC. · OPK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Md Et Al Frost
Officer — CEO & Chairman · Director · 10% Owner
Period of report
Aug 16, 2017
Accepted (ET)
Aug 17, 2017 · 7:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000944809

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 16, 2017P1,600$6.015A164,072,243ISee Footnote
Common StockF1Aug 16, 2017P400$6.0175A164,072,643ISee Footnote
Common StockF1Aug 16, 2017P5,000$6.02A164,077,643ISee Footnote
Common StockF1Aug 16, 2017P1,800$6.03A164,079,443ISee Footnote
Common StockF1Aug 16, 2017P5,100$6.035A164,084,543ISee Footnote
Common StockF1Aug 16, 2017P300$6.0375A164,084,843ISee Footnote
Common StockF1Aug 16, 2017P4,600$6.04A164,089,443ISee Footnote
Common StockF1Aug 16, 2017P6,600$6.045A164,096,043ISee Footnote
Common StockF1Aug 16, 2017P4,600$6.05A164,100,643ISee Footnote
Common StockF1Aug 16, 2017P100$6.0575A164,100,743ISee Footnote
Common StockF1Aug 16, 2017P4,900$6.06A164,105,643ISee Footnote
Common StockF1Aug 16, 2017P200$6.065A164,105,843ISee Footnote
Common StockF1Aug 16, 2017P100$6.0675A164,105,943ISee Footnote
Common StockF1Aug 16, 2017P4,700$6.07A164,110,643ISee Footnote
Common Stockholding———3,068,951D
Common StockF2holding———20,091,062ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses